SCHEMBL18039290

SCHEMBL18039290

Cc1ccc2[nH]c(Sc3nc4c(n3Cc3cncs3)CNCN4C)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TPH2 Q8IWU9 12/20 0.55
▸ TPH1 P17752 9/20 0.55
▸ PDE10A Q9Y233 1/20 0.33
▸ TLR9 Q9NR96 2/20 0.33
▸ TLR8 Q9NR97 2/20 0.33
▸ TLR7 Q9NYK1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18036486 0.78 TPH2 (0.88) TPH2TPH1
SCHEMBL18036526 0.60 TPH2 (0.86) TPH2TPH1
SCHEMBL18036488 0.60 TPH2 (0.87) TPH2TPH1
SCHEMBL4597359 0.58 ALDH1A1 (0.53) —
SCHEMBL8366653 0.57 CYP1A2 (0.54) —
Hydrochloric Acid SCHEMBL10492855 0.57 TSHR (0.70) —
SCHEMBL8077743 0.57 MAPT (0.41) —
SCHEMBL10492786 0.56 MEN1 (0.64) —
Hydrochloric Acid SCHEMBL10492880 0.56 RAB9A (0.73) —
SCHEMBL2107585 0.56 MYC (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262044-A1 XANTHINE DERIVATIVES, THEIR USE AS A MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THE SAME Max-Delbrück-Centrum für Molekulare Medizin (DE) 2018-01-03 — — EP disclosed
WO-2016135199-A1 XANTHINE DERIVATIVES, THEIR USE AS A MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THE SAME Max-Delbrück-Centrum für Molekulare Medizin (DE) 2016-09-01 — — WO disclosed
Send feedback